BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Asgard Therapeutics Selects Exothera for Clinical Manufacturing of Cancer Gene Therapy AT-108

Asgard Therapeutics, a privately held biotech company pioneering in vivo direct cell reprogramming for cancer immunotherapy, today announced it s...

June 12, 2024 | News

Zymeworks Secures $8 Million Milestone Payment and Advances Cancer Treatment with FDA and NMPA Approvals

Pursuant to the terms of the licensing agreement between Zymeworks and BeiGene, Zymeworks is entitled to receive an $8 million milestone payment from Bei...

June 11, 2024 | News

Alphamab Oncology and ArriVent BioPharma Forge Strategic Collaboration to Develop Novel Antibody Drug Conjugates

Alphamab Oncology announced that Jiangsu Alphamab Biopharmaceuticals Co., Ltd. , a wholly-owned subsidiary of the Company, entered into a research an...

June 06, 2024 | News

Annogen and Orchard Therapeutics Partner for Innovative Gene Therapy Research

Annogen, a company with expertise in bespoke promoter design and gene expression engineering, announced a research collaboration with Orchard Therape...

June 06, 2024 | News

HuidaGene Therapeutics and Synthego Corporation Forge Licensing Agreement for Advanced CRISPR Nuclease

HuidaGene Therapeutics ("HuidaGene"), a global clinical-stage biotechnology company focused on advancing CRISPR-based genomic medicines, and Synthego Corpo...

May 31, 2024 | News

Cytiva Launches Sefia: Advanced Platform to Transform CAR T Cell Therapy Manufacturing

Sefia cell therapy manufacturing platform comes out of Cytiva's extensive R&D expertise and in-depth understanding of CAR T manufacturing Automation...

May 30, 2024 | News

GCCL Introduces First ddPCR Device in South Korea for Enhanced Clinical Trial Sample Analysis

Introduced the first ddPCR device in Korea to provide high-quality clinical trial sample analysis services by increasing test accuracy Differentiate glo...

May 23, 2024 | News

Ractigen Therapeutics' saRNA Drug RAG-01 Receives Fast Track Designation from FDA

Ractigen Therapeutics, a pioneering developer of small activating RNA (saRNA) therapeutics, proudly announces that its flagship program, RAG-01, has been g...

May 22, 2024 | News

Cellipont Bioservices Partners with Adva Biotechnology to Launch Innovative ADVA X3® Platform

Cellipont Bioservices, a leading cell therapy Contract Development and Manufacturing Organization (CDMO), and Adva Biotechnology, an Israel-based...

May 08, 2024 | News

Cytiva Innovates in Gene Therapy with Launch of ELEVECTA Cell Lines

Cytiva, a global leader in life sciences, has introduced its pioneering ELEVECTA cell lines, marking a significant advancement in...

May 07, 2024 | News

Takara Bio USA Introduces Innovative Lenti-X Transduction Sponge for Gene Delivery

Takara Bio USA, Inc., a wholly owned subsidiary of Takara Bio Inc., announced the launch of the Lenti-X™ Transduction Sponge, a first-to-market disso...

May 07, 2024 | News

Latus Bio Launches with $54 Million Series A to Advance CNS Gene Therapy

Latus Bio, a biotechnology company developing novel gene therapy candidates for disorders of the central nervous system (CNS), today announced its launch a...

May 03, 2024 | News

MiLaboratories and Miltenyi Biotec Forge Partnership to Advance Next-Generation Therapies

MiLaboratories, a leader in RNA immune technologies, and Miltenyi Biotec, a global pioneer in biotechnology, are excited to announce a landmark partnership...

April 29, 2024 | News

Hyundai Bioscience Targets p53 Gene Mutations with Novel Niclosamide-Based Cancer Therapy

The only solution for intractable cancer caused by mutations in the p53 gene Planning clinical trials targeting cancer patients with no available treatm...

April 26, 2024 | News

Stay Connected